dual PI3K gamma/delta inhibitors (Cellzome)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Namedual PI3K gamma/delta inhibitors (Cellzome)

Drug Alias Namedual phosphatidylinositol-3 kinase gamma/delta inhibitors (Cellzome)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphatidylinositol 3 kinase gamma inhibitorsPhosphatidylinositol 3 kinase delta inhibitors

TargetsPhosphatidylinositol-4,5-Bisphosphate 3 kinase gammaPhosphatidylinositol 3 kinase delta

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCellzome Gmbh

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCellzome Gmbh

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A